Back
Phathom Pharmaceuticals Stock Price Chart
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm
Buy
60
PHAT
Phathom Pharmaceuticals
Last Price:
18.76
Seasonality Move:
-9.67%
7 Day Trial
ALL ACCESS PASS
$
7
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- The current trend is moderately bullish and PHAT is experiencing selling pressure, which indicates risk of future bearish movement.
Phathom Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.72 | Sell |
| 20-day SMA: | 17.08 | Buy |
| 50-day SMA: | 13.94 | Buy |
| 200-day SMA: | 10.51 | Buy |
| 8-day EMA: | 18.52 | Buy |
| 20-day EMA: | 17.13 | Buy |
| 50-day EMA: | 14.77 | Buy |
| 200-day EMA: | 11.7 | Buy |
Phathom Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.57 | Buy |
| Relative Strength Index (14 RSI): | 66.31 | Buy |
| Chaikin Money Flow: | -707543 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.87 - 18.59) | Buy |
| Bollinger Bands (100): | (9.46 - 14.88) | Buy |
Phathom Pharmaceuticals Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Phathom Pharmaceuticals Stock
Is Phathom Pharmaceuticals Stock a Buy?
- Phathom Pharmaceuticals share price is 18.69 while PHAT 8-day simple moving average is 18.72, which is a Sell signal.
- The stock price of PHAT is 18.69 while Phathom Pharmaceuticals 20-day SMA is 17.08, which makes it a Buy.
- Phathom Pharmaceuticals 50-day simple moving average is 13.94 while PHAT share price is 18.69, making it a Buy technically.
- PHAT stock price is 18.69 and Phathom Pharmaceuticals 200-day simple moving average is 10.51, creating a Buy signal.
PHAT Technical Analysis vs Fundamental Analysis
Buy
60
Phathom Pharmaceuticals (PHAT)
is a Buy
Is Phathom Pharmaceuticals a Buy or a Sell?
-
Phathom Pharmaceuticals stock is rated a Buy
The current Phathom Pharmaceuticals [PHAT] share price is $18.69. The Score for PHAT is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
Phathom Pharmaceuticals Stock Info
Market Cap:
1.28B
Price in USD:
18.69
Share Volume:
1.27M
Phathom Pharmaceuticals 52-Week Range
52-Week High:
19.71
52-Week Low:
6.07
Buy
60
Phathom Pharmaceuticals (PHAT)
is a Buy
Phathom Pharmaceuticals Share Price Forecast
-
What is the Phathom Pharmaceuticals stock price today?
The Phathom Pharmaceuticals stock price is 18.69 USD today. -
Will PHAT stock go up or go down?
Phathom Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Phathom Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Phathom Pharmaceuticals is not overvalued.
Is Phathom Pharmaceuticals Stock a Buy?
- Phathom Pharmaceuticals share price is 18.69 while PHAT 8-day exponential moving average is 18.52, which is a Buy signal.
- The stock price of PHAT is 18.69 while Phathom Pharmaceuticals 20-day EMA is 17.13, which makes it a Buy.
- Phathom Pharmaceuticals 50-day exponential moving average is 14.77 while PHAT share price is 18.69, making it a Buy technically.
- PHAT stock price is 18.69 and Phathom Pharmaceuticals 200-day simple moving average is 11.70, creating a Buy signal.
Fundamental Analysis of Phathom Pharmaceuticals
Is Phathom Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.50 per share, an increase next quarter of $0.54 per share, a decrease this year of $1.71 per share, and an increase next year of $1.35 per share.
Technical Analysis of Phathom Pharmaceuticals
Should I short Phathom Pharmaceuticals stock?
- PHAT Moving Average Covergence Divergence (MACD) indicator is 1.57, suggesting Phathom Pharmaceuticals is a Buy
- Phathom Pharmaceuticals Relative Strength Index (RSI) is 66.31, which suggest Phathom Pharmaceuticals is overbought
- The Bollinger Bands (25) for Phathom Pharmaceuticals is (13.87 - 18.59), which suggest Phathom Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Phathom Pharmaceuticals is (9.46 - 14.88), which suggest Phathom Pharmaceuticals is a Buy
* Phathom Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.